212 related articles for article (PubMed ID: 9680353)
1. CD164, a novel sialomucin on CD34(+) and erythroid subsets, is located on human chromosome 6q21.
Watt SM; Bühring HJ; Rappold I; Chan JY; Lee-Prudhoe J; Jones T; Zannettino AC; Simmons PJ; Doyonnas R; Sheer D; Butler LH
Blood; 1998 Aug; 92(3):849-66. PubMed ID: 9680353
[TBL] [Abstract][Full Text] [Related]
2. CD164 monoclonal antibodies that block hemopoietic progenitor cell adhesion and proliferation interact with the first mucin domain of the CD164 receptor.
Doyonnas R; Yi-Hsin Chan J; Butler LH; Rappold I; Lee-Prudhoe JE; Zannettino AC; Simmons PJ; Bühring HJ; Levesque JP; Watt SM
J Immunol; 2000 Jul; 165(2):840-51. PubMed ID: 10878358
[TBL] [Abstract][Full Text] [Related]
3. Functionally defined CD164 epitopes are expressed on CD34(+) cells throughout ontogeny but display distinct distribution patterns in adult hematopoietic and nonhematopoietic tissues.
Watt SM; Butler LH; Tavian M; Bühring HJ; Rappold I; Simmons PJ; Zannettino AC; Buck D; Fuchs A; Doyonnas R; Chan JY; Levesque JP; Peault B; Roxanis I
Blood; 2000 May; 95(10):3113-24. PubMed ID: 10807777
[TBL] [Abstract][Full Text] [Related]
4. The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis.
Zannettino AC; Bühring HJ; Niutta S; Watt SM; Benton MA; Simmons PJ
Blood; 1998 Oct; 92(8):2613-28. PubMed ID: 9763543
[TBL] [Abstract][Full Text] [Related]
5. Epitope recognition of antibodies that define the sialomucin, endolyn (CD164), a negative regulator of haematopoiesis.
Jorgensen-Tye B; Levesque JP; Royle L; Doyonnas R; Chan JY; Dwek RA; Rudd PM; Harvey DJ; Simmons PJ; Watt SM
Tissue Antigens; 2005 Mar; 65(3):220-39. PubMed ID: 15730515
[TBL] [Abstract][Full Text] [Related]
6. Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase.
Rappold I; Ziegler BL; Köhler I; Marchetto S; Rosnet O; Birnbaum D; Simmons PJ; Zannettino AC; Hill B; Neu S; Knapp W; Alitalo R; Alitalo K; Ullrich A; Kanz L; Bühring HJ
Blood; 1997 Jul; 90(1):111-25. PubMed ID: 9207445
[TBL] [Abstract][Full Text] [Related]
7. Relationship between novel isoforms, functionally important domains, and subcellular distribution of CD164/endolyn.
Chan JY; Lee-Prudhoe JE; Jorgensen B; Ihrke G; Doyonnas R; Zannettino AC; Buckle VJ; Ward CJ; Simmons PJ; Watt SM
J Biol Chem; 2001 Jan; 276(3):2139-52. PubMed ID: 11027692
[TBL] [Abstract][Full Text] [Related]
8. Identification of CD34+ subsets after glycoprotease selection: engraftment of CD34+Thy-1+Lin- stem cells in fetal sheep.
Sutherland DR; Yeo EL; Stewart AK; Nayar R; DiGiusto R; Zanjani E; Hoffman R; Murray LJ
Exp Hematol; 1996 Jun; 24(7):795-806. PubMed ID: 8647230
[TBL] [Abstract][Full Text] [Related]
9. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
[TBL] [Abstract][Full Text] [Related]
10. Colocalization analysis of sialomucins CD34 and CD164.
McGuckin CP; Forraz N; Baradez MO; Lojo-Rial C; Wertheim D; Whiting K; Watt SM; Pettengell R
Stem Cells; 2003; 21(2):162-70. PubMed ID: 12634412
[TBL] [Abstract][Full Text] [Related]
11. Surface antigen expression on CD34+ cord blood cells: comparative analysis by flow cytometry and limiting dilution (LD) RT-PCR of chymopapain-treated or untreated cells.
Ziegler BL; Thoma SJ; Lamping CP; Valtieri M; Müller R; Samoggia P; Bühring HJ; Peschle C; Fliedner TM
Cytometry; 1996 Sep; 25(1):46-57. PubMed ID: 8875054
[TBL] [Abstract][Full Text] [Related]
12. Endolyn (CD164) modulates the CXCL12-mediated migration of umbilical cord blood CD133+ cells.
Forde S; Tye BJ; Newey SE; Roubelakis M; Smythe J; McGuckin CP; Pettengell R; Watt SM
Blood; 2007 Mar; 109(5):1825-33. PubMed ID: 17077324
[TBL] [Abstract][Full Text] [Related]
13. The heparin binding PECAM-1 adhesion molecule is expressed by CD34+ hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes.
Watt SM; Williamson J; Genevier H; Fawcett J; Simmons DL; Hatzfeld A; Nesbitt SA; Coombe DR
Blood; 1993 Nov; 82(9):2649-63. PubMed ID: 7693043
[TBL] [Abstract][Full Text] [Related]
14. Extended flow cytometry characterization of normal bone marrow progenitor cells by simultaneous detection of aldehyde dehydrogenase and early hematopoietic antigens: implication for erythroid differentiation studies.
Mirabelli P; Di Noto R; Lo Pardo C; Morabito P; Abate G; Gorrese M; Raia M; Pascariello C; Scalia G; Gemei M; Mariotti E; Del Vecchio L
BMC Physiol; 2008 May; 8():13. PubMed ID: 18510759
[TBL] [Abstract][Full Text] [Related]
15. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
[TBL] [Abstract][Full Text] [Related]
16. CD164--a novel sialomucin on CD34+ cells.
Watt SM; Chan JY
Leuk Lymphoma; 2000 Mar; 37(1-2):1-25. PubMed ID: 10721766
[TBL] [Abstract][Full Text] [Related]
17. Expression of novel surface antigens on early hematopoietic cells.
Bühring HJ; Seiffert M; Bock TA; Scheding S; Thiel A; Scheffold A; Kanz L; Brugger W
Ann N Y Acad Sci; 1999 Apr; 872():25-38; discussion 38-9. PubMed ID: 10372108
[TBL] [Abstract][Full Text] [Related]
18. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
[TBL] [Abstract][Full Text] [Related]
19. The characterization, molecular cloning, and expression of a novel hematopoietic cell antigen from CD34+ human bone marrow cells.
Uchida N; Yang Z; Combs J; Pourquié O; Nguyen M; Ramanathan R; Fu J; Welply A; Chen S; Weddell G; Sharma AK; Leiby KR; Karagogeos D; Hill B; Humeau L; Stallcup WB; Hoffman R; Tsukamoto AS; Gearing DP; Péault B
Blood; 1997 Apr; 89(8):2706-16. PubMed ID: 9108388
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
